BerGenBio ASA

BRRGF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$139-$190-$302-$309
Dep. & Amort.$0$0$1$1
Deferred Tax$0$0$0$1
Stock-Based Comp.$6$3$3$7
Change in WC-$12-$33$9$0
Other Non-Cash-$8-$5$0-$3
Operating Cash Flow-$153-$225-$288-$303
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4$3$3$0
Investing Cash Flow$4$3$3$3
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$139$262$3$17
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$9-$37-$0-$1
Financing Cash Flow$130$225$3$16
Forex Effect$4$3-$4-$1
Net Chg. in Cash-$16$6-$286-$285
Supplemental Information
Beg. Cash$156$151$437$722
End Cash$140$156$151$437
Free Cash Flow-$153-$225-$288-$303